POSTED: September 04, 2015

Dr. Laurence Klotz On Active Surveillance + PCa Screening

Prostate Forum recently spoke with Dr. Laurence Klotz of Sunnybrook Health Sciences Centre in Toronto. Below are his comments on how active surveillance, over-treatment, and current US prostate cancer screening recommendations intersect. You can read the entire interview in Prostate Forum Volume 15 Number 7.


Dr. Klotz said: “We need to embrace active surveillance in order to rehabilitate prostate cancer screening. If  we embrace surveillance as a community, the number of patients needing treatment will go down and we will demonstrate that the proportion of patients we’re treating is not that different from the proportion destined to die from prostate cancer without treatment. If we do that, eventually screening will become respectable again.

At the moment, there is a very awkward situation in which a respected group like the US Preventative Services Task Force recommends against screening and yet we have an entire community of specialists recommending routine screening. We need more consistency among medical professionals. I think the people in the field really believe in screening; there is a benefit that has been shown in large-scale trials. But it has to be married to conservative management in favorable risk patients. A fundamental shift has to take place.”

Leave A Comment